ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Kiniksa Pharmaceuticals International PLC

Kiniksa Pharmaceuticals International PLC (KNSA)

21.97
-0.505
( -2.25% )
Updated: 13:58:37

Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

Key stats and details

Current Price
21.97
Bid
21.93
Ask
22.01
Volume
177,492
21.52 Day's Range 22.26
14.12 52 Week Range 28.15
Market Cap
Previous Close
22.475
Open
22.26
Last Trade
1
@
21.9719
Last Trade Time
14:00:37
Financial Volume
$ 3,904,816
VWAP
22.00
Average Volume (3m)
364,046
Shares Outstanding
71,243,712
Dividend Yield
-
PE Ratio
112.09
Earnings Per Share (EPS)
0.2
Revenue
270.26M
Net Profit
14.08M

About Kiniksa Pharmaceuticals International PLC

Kiniksa Pharmaceuticals Ltd is a clinical-stage biopharmaceutical company focused on discovering, acquiring, developing, and commercializing therapeutic medicines for patients suffering from debilitating diseases. Its clinical-stage product candidates include Rilonacept, for the treatment of recurre... Kiniksa Pharmaceuticals Ltd is a clinical-stage biopharmaceutical company focused on discovering, acquiring, developing, and commercializing therapeutic medicines for patients suffering from debilitating diseases. Its clinical-stage product candidates include Rilonacept, for the treatment of recurrent pericarditis, a debilitating inflammatory cardiovascular disease; Mavrilimumab, a monoclonal antibody for the treatment of giant cell arteritis; Vixarelimab; and KPL-404. Show more

Sector
Pharmaceutical Preparations
Industry
Pharmaceutical Preparations
Website
Headquarters
London, Gbr
Founded
-
Kiniksa Pharmaceuticals International PLC is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker KNSA. The last closing price for Kiniksa Pharmaceuticals was $22.48. Over the last year, Kiniksa Pharmaceuticals shares have traded in a share price range of $ 14.12 to $ 28.15.

Kiniksa Pharmaceuticals currently has 71,243,712 shares outstanding. The market capitalization of Kiniksa Pharmaceuticals is $1.60 billion. Kiniksa Pharmaceuticals has a price to earnings ratio (PE ratio) of 112.09.

KNSA Latest News

Kiniksa Pharmaceuticals Reports Third Quarter 2024 Financial Results and Recent Portfolio Execution

– ARCALYST® (rilonacept) Q3 2024 net product revenue of $112.2 million, representing 73% year-over-year growth –– ARCALYST 2024 expected net product revenue increased to $410 - $420 million ––...

Kiniksa Pharmaceuticals Partners with GRAMMY® Award-Winning Singer-Songwriter, Carly Pearce, in Expansion of Life DisRPted™ Campaign to Drive Awareness of Recurrent Pericarditis

– National campaign to elevate experiences from the recurrent pericarditis community and empower patients to seek care – LONDON, Oct. 28, 2024 (GLOBE NEWSWIRE) -- Kiniksa Pharmaceuticals...

Kiniksa Pharmaceuticals to Report Third Quarter 2024 Financial Results on October 29, 2024

LONDON, Oct. 22, 2024 (GLOBE NEWSWIRE) -- Kiniksa Pharmaceuticals International, plc (Nasdaq: KNSA) announced today that it will host a conference call and live webcast on Tuesday, October 29...

NHL Hall-of-Famer, Henrik Lundqvist, Teams Up with Kiniksa Pharmaceuticals to Launch Life DisRPted™ Campaign to Drive Awareness of Recurrent Pericarditis

LONDON, Oct. 01, 2024 (GLOBE NEWSWIRE) -- Kiniksa Pharmaceuticals International, plc (Nasdaq: KNSA) (Kiniksa), a commercial-stage biopharmaceutical company, has teamed up with National Hockey...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
1-6.095-21.717441653328.06528.1520.255249018123.57236102CS
4-2.51-10.253267973924.4828.1520.255232279525.06634434CS
12-3.23-12.817460317525.228.1520.255236404625.3527789CS
261.839.0863952333720.1428.1517.3841116623.20135192CS
525.7435.366605052416.2328.1514.1241781520.8028646CS
1567.9356.481481481514.0428.157.3639185015.99381578CS
26014.49193.716577547.48336.2838575816.31295873CS

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
SPPLSIMPPLE Ltd
$ 0.916
(186.25%)
310.91M
NUWENewellis Inc
$ 2.65
(94.85%)
90.21M
STAFStaffing 360 Solutions Inc
$ 2.83
(66.47%)
49.42M
ADNAdvent Technologies Holdings Inc
$ 3.0468
(60.36%)
63.15M
OMICSingular Genomics Systems Inc
$ 21.2921
(58.19%)
285.17k
FIACFocus Impact Acquisition Corporation
$ 1.00
(-88.74%)
172
SSPEW Scripps Company
$ 2.205
(-37.36%)
2.88M
INVZWInnoviz Technologies Ltd
$ 0.0642
(-33.13%)
2k
GCTKGlucoTrack Inc
$ 1.20
(-31.03%)
66.88k
ILLRTriller Group Inc
$ 3.00
(-29.91%)
1.93M
SPPLSIMPPLE Ltd
$ 0.916
(186.25%)
310.91M
ELABElevai Labs Inc
$ 0.0203
(-29.76%)
217.37M
SQQQProShares UltraPro Short QQQ
$ 7.4414
(0.02%)
132.36M
NVDANVIDIA Corporation
$ 138.1001
(1.99%)
129.99M
PLUGPlug Power Inc
$ 2.495
(19.38%)
90.35M